# Phase IV Study to Compare Efficacy and Safety of Plavix 75mg With Astrix 100mg and Closone

Study · id `cardio:ct-nct01765452` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01765452](<https://clinicaltrials.gov/study/NCT01765452>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01765452

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 285 participants.

## Technical summary

Registry record NCT01765452. Randomized; no masking; primary purpose treatment. Start 2012-10 (registry gives no type); primary completion 2013-08 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 285 participants (enrolled count; ClinicalTrials.gov record NCT01765452, source copy `cardio:ctgov-nct01765452-2014-05-12`, retrieved 2026-10-26)
- Start date: 2012-10 (registry gives no type) (ClinicalTrials.gov record NCT01765452, source copy `cardio:ctgov-nct01765452-2014-05-12`, retrieved 2026-10-26)
- Primary completion: 2013-08 (actual) (ClinicalTrials.gov record NCT01765452, source copy `cardio:ctgov-nct01765452-2014-05-12`, retrieved 2026-10-26)
- Completion: 2013-08 (actual) (ClinicalTrials.gov record NCT01765452, source copy `cardio:ctgov-nct01765452-2014-05-12`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT01765452, source copy `cardio:ctgov-nct01765452-2014-05-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01765452-2014-05-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Phase IV Study to Compare Efficacy and Safety of Plavix 75mg With Astrix 100mg and Closone
- Condition: Coronary Artery Disease
- Intervention (Drug): Closone
- Intervention (Drug): Plavix with Astrix
- Lead sponsor: HK inno.N Corporation
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: HK inno.N Corporation (`cardio:org-hk-inno-n-corporation`)

## Provenance

Content hash: 8a1265442d8cac632eaa634fdc4913e3c3c072d312b0a0fe67abd83be8f8649a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
